2016_Head & Neck COURSE BOOK

Low risk

High risk

• Acinic cell carcinom • Polymorphous low‐grade  adenocarcinoma • Basal cell adenocarcinoma • Epitelial‐myoepitelial carcinoma • Well / moderately differentiated mucoepidermoid carcinoma • Adenocarcinoma NOS well differentiated • Non‐invasive and minimally invasive carcinoma in pleomorph adenoma • Clear celle carcinoma

• Adenoid cystic carcinoma • Adenocarcinoma NOS moderate‐ poorly differentiated • Carcinoma in pleomorph adenoma, invasion >1.5 mm  • Poorly differentiated mucoepidermoid carcinoma • Salivary duct carcinoma • Primary squamous cell carcinoma • Undifferentiated carcinoma (lymphoeptelial carcinoma) • Large cell carcinoma • Mucinous adenocarcinoma O i • ncocytary carc noma • Carcinosarcoma • Small cell carcinoma • Myoepitelial carcinoma

• Sialoblastoma

DAHANCA guidelines for management  of salivary gland tumours 2010

www.DAHANCA.dk